Pancreatic Cancer Research

ResearcherOita UniversityActive in the last 2 years

Shusaku Kurogi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0004-8924-7946; OpenAlex author ID A5075342244. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Annexin A8 Drives MEK Inhibitor Resistance, Providing a Druggable Target for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1535-7163.mct-25-0638↗
  2. Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor. Co-author DOI 10.1111/cas.15735↗
  3. Downregulation of ZNF395 Drives Progression of Pancreatic Ductal Adenocarcinoma through Enhancement of Growth Potential. Co-author DOI 10.1159/000514593↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Teijiro Hirashita · 3 shared papers, 2021–2026 · strength 0.51
  2. Masafumi Inomata · 3 shared papers, 2021–2026 · strength 0.51
  3. Naoki Hijiya · 3 shared papers, 2021–2026 · strength 0.51
  4. Masatsugu Moriyama · 3 shared papers, 2021–2026 · strength 0.51
  5. Kazunari Murakami · 2 shared papers, 2021–2023 · strength 0.25
  6. Kazuyoshi Yanagihara · 1 shared paper, 2023 · strength 0.14
  7. Kohei Amada · 1 shared paper, 2023 · strength 0.14
  8. Keisuke Kinoshita · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.